Peripheral arterial occlusive disease and ischemic disease of the lower limbs are not the same condition. A proposed unambiguous Italian terminology for defining Peripheral arterial disease of lower limbs and related clinical/therapeutic implications

Italian Journal of Medicine

Volumn 8, Issue 1, 2014, Pages 1-5

  Meini, Simone ^a   Melillo, Elio ^b   Migliacci, Rino ^c   Nicolosi, Gabriele ^d   Panigada, Grazia ^e   Landini, Giancarlo ^f  

^a UO Medicina Interna Spedali Riuniti S Maria Maddalena ASL Pisa   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UO Medicina Interna Ospedale Val di Chiana   (Italy)

^d AO Villa Sofia   (Italy)

^e Ospedale SS Cosma e Damiano   (Italy)

^f SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

Co morbidity; Critical limb ischemia; Iloprost; Lower extremity arterial disease; Peripheral arterial disease

Indexed keywords

ARTERY OCCLUSION; CRITICAL LIMB ISCHEMIA; EDITORIAL; HUMAN; ITALY; LIMB ISCHEMIA; MEDICAL TERMINOLOGY; NOMENCLATURE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SEMANTICS;

EID: 84901300853     PISSN: 18779344     EISSN: 18779352     Source Type: Journal    
DOI: 10.4081/itjm.2014.387     Document Type: Editorial

References (16)

1. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Circulation 2006;113:e463-e654.
2. Marzilli M, Merz CN, Boden WE, et al. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol 2012;60:951-6.
3. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45:S5-S67. (Pubitemid 46151680)
4. th ed: American College of Chest Physicians. Evidence-based clinical practice guidelines. Antithrombotic therapy in peripheral artery disease. Chest 2012;141:e669S-e690S.
5. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 2004;292:453-61. (Pubitemid 38988954)
6. Kinlay S. Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease. Circulation 2013;127:1241-50.
7. Atkins LM, Gardner AW. The relationship between lower extremity functional strength and severity of peripheral arterial disease. Angiology 2004;55:347-55. (Pubitemid 38924364)
8. Szuba A, Oka RK, Harada R, Cooke JP. Limb hemodynamics are not predictive of functional capacity in patients with PAD. Vasc Med 2006;11:155-63. (Pubitemid 46099259)
9. Anderson JD, Epstein FH, Meyer CH, et al. Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism. J Am Coll Cardiol 2009;54:628-35.
10. McDermott MM, Liu K, Carroll TJ, et al. Superficial femoral artery plaque and functional performance in peripheral arterial disease: Walking and Leg Circulation Study (WALCS III). JACC Cardiovasc Imaging 2011;4:730-9.
11. Hiatt WR, Regensteiner JG, Hargarten ME, et al. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990;81:602-9. (Pubitemid 20055969)
12. Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:2020-45.
13. TASC. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). Int Angiol 2000;19:I-XXIV;1-304.
14. Task force on diabetes and cardiovascular disease of ESC/EASD. Medical treatment of critical limb ischemia. Eur Heart J 2007;28:88-136.
15. Piaggesi A, Vallini V, Iacopi E, et al. Il ruolo di iloprost nella gestione della arteriopatia periferica nel diabete mellito. Minerva Cardioangiologica 2011;59:101-8.
16. Melillo E, Nuti M, Balbarini A, et al. [Diagnostic and therapeutic algorhythm in lower critical limb ischemia where immediate revascularization procedures are impossible.] Trends Med 2006;6:201-34. [In Italian].